(MedPage Today) — MADRID — For patients with cardiovascular disease, efforts to raise potassium levels paid off in terms of a reduction in the risk of ventricular arrhythmias in the POTCAST randomized trial.
High-risk patients, comprising…
Source link : https://www.medpagetoday.com/meetingcoverage/esc/117226
Author :
Publish date : 2025-08-29 15:51:00
Copyright for syndicated content belongs to the linked Source.
